Sanofi
A global biopharmaceutical company that discovers, develops, and markets medicines and vaccines.
SAN | PA
Overview
Corporate Details
- ISIN(s):
- FR0000120578 (+39 more)
- LEI:
- 549300E9PC51EN656011
- Country:
- France
- Address:
- 46 AVENUE DE LA GRANDE ARMEE, 75017 PARIS
- Sector:
- Manufacturing
Description
Sanofi is a global biopharmaceutical company dedicated to the discovery, development, manufacturing, and marketing of therapeutic solutions. The company's portfolio includes a wide range of medicines and vaccines designed to improve human health. Sanofi focuses on several key therapeutic areas, including immunology, oncology, rare diseases, neurology, and vaccines. Emphasizing a research-driven approach, the company increasingly utilizes artificial intelligence to innovate and accelerate the delivery of new treatments for patients worldwide. Sanofi is also a producer of active pharmaceutical ingredients.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-02-13 07:00 |
Press Release: Update on extraintestinal pathogenic E. coli vaccine phase 3 cli…
|
English | 156.6 KB | ||
| 2025-02-11 14:10 |
Franchissement de seuil
|
French | 200.7 KB | ||
| 2025-02-10 19:00 |
Sanofi: Disclosure of trading in own shares
|
English | 1.9 MB | ||
| 2025-02-10 19:00 |
Sanofi : Déclaration des transactions sur actions propres
|
French | 1.8 MB | ||
| 2025-02-07 17:14 |
6-K
|
English | 21.5 KB | ||
| 2025-02-07 07:00 |
Press Release: Execution of a share buyback agreement for up to €2 billion
|
English | 142.3 KB | ||
| 2025-02-07 07:00 |
Communiqué de presse : Sanofi annonce la signature d’un mandat de rachat d'acti…
|
French | 129.3 KB | ||
| 2025-02-03 18:14 |
6-K
|
English | 35.2 KB | ||
| 2025-02-03 07:30 |
Communiqué de presse : Sanofi annonce un rachat d'actions à L'Oréal
|
French | 165.1 KB | ||
| 2025-02-03 07:30 |
Press Release: Sanofi announces buy back of shares from L’Oréal
|
English | 166.5 KB | ||
| 2025-01-31 07:00 |
Communiqué de presse : Sarclisa est le premier anti-CD38 approuvé en Chine pour…
|
French | 182.9 KB | ||
| 2025-01-31 07:00 |
Press Release: Sarclisa is the first anti-CD38 treatment approved in China for …
|
English | 174.5 KB | ||
| 2025-01-30 15:50 |
6-K
|
English | 774.6 KB | ||
| 2025-01-30 07:30 |
Press Release: Q4 sales growth of 10.3%, 2024 business EPS guidance exceeded, a…
|
English | 531.9 KB | ||
| 2025-01-30 07:30 |
Communiqué de presse : Croissance des ventes de 10,3% au T4. Objectif du BNPA d…
|
French | 573.1 KB |
Automate Your Workflow. Get a real-time feed of all Sanofi filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Sanofi
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Sanofi via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2024-05-02 | N/A | Other | Buy | 71,423 | N/A |
| 2024-04-26 | N/A | Other | Buy | 1,000 | 91,380.00 EUR |
| 2023-06-09 | N/A | Other | Buy | 9 | 856.04 EUR |
| 2023-05-02 | N/A | Other | Buy | 65,205 | 6,364,008.00 EUR |
| 2023-05-02 | N/A | Other | Buy | 500 | 48,835.00 EUR |
Peer Companies
